Scientific American has published an article describing the work of Salmaan Keshavjee, physician with Partners in Health and chair of the World Health Organization’s Green Light Committee.

Dr Keshavjee’s main focus is on improving the treatment of multi-drug resistant tuberculosis (MDR-TB) in developing countries. The article begins with an account of his recent visit to Lesotho to coordinate construction of a new TB hospital and lab. He takes the view that MDR-TB can be treated successfully even in low-resource settings and calls for more imagination and ingenuity in finding new ways of providing care to those who need it. Last year his mission took him to over 20 countries across the world.